Appropriate Time for Primaquine Treatment to Reduce Plasmodium falciparum Transmission in Hypoendemic Areas
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Artemesinin-combination therapies (ACT) for falciparum malaria reduce gametocyte carriage, and therefore reduce transmission. Artemisinin derivatives will act against only young gametocytes whereas primaquine acts on mature gametocytes which are present usually in the circulation at the time when the patient presents for treatment. Both artemisinin derivatives and primaquine have short half-lives, less than 1 hr and 7 hr, respectively. Therefore, asexual parasites or young gametocytes remain after completed ACT. A single dose of primaquine (0.50-0.75 mg base/kg) at the end of ACT can kill only mature gametocytes but cannot kill young gametocytes (if present). Remaining asexual forms after completion of ACT course, e.g., artesunate-mefloquine for 3 days, may develop to mature gametocytes 7-15 days later. Thus,an additional dose of primaquine (0.50-0.75 mg base/kg) given 2 weeks after ACT completion may be beneficial for killing remaining mature gametocytes and contribute to more interruption of Plasmodium falciparum transmission than giving only 1 single dose of primaquine just after completing ACT.
Abstract
Artemesinin-combination therapies (ACT) for falciparum malaria reduce gametocyte carriage, and therefore reduce transmission. Artemisinin derivatives will act against only young gametocytes whereas primaquine acts on mature gametocytes which are present usually in the circulation at the time when the patient presents for treatment. Both artemisinin derivatives and primaquine have short half-lives, less than 1 hr and 7 hr, respectively. Therefore, asexual parasites or young gametocytes remain after completed ACT. A single dose of primaquine (0.50-0.75 mg base/kg) at the end of ACT can kill only mature gametocytes but cannot kill young gametocytes (if present). Remaining asexual forms after completion of ACT course, e.g., artesunate-mefloquine for 3 days, may develop to mature gametocytes 7-15 days later. Thus,an additional dose of primaquine (0.50-0.75 mg base/kg) given 2 weeks after ACT completion may be beneficial for killing remaining mature gametocytes and contribute to more interruption of Plasmodium falciparum transmission than giving only 1 single dose of primaquine just after completing ACT.
참고문헌 (20)
- Rieckmann KH, "Gametocidal and sporontocidal effects of primaquine and of sulfadoxine with pyrimethamine in a chloroquineresistant strain of Plasmodium falciparum", Bull WHO, 38, pp.625~632 (1968)
- Lawpoolsri S, "Optimal timing of primaquine treatment to reduce Plasmodium falciparum transmission in low endemicity Thai-Myanmar border populations", Malaria J, 8, pp.159~ (2009)
- Baird JK, "Primaquine therapy for malaria", Clin Infect Dis, 39, pp.1336~1345 (2004)
- World Health Organization, "Guidelines for the treatment of malaria. 1st ed", pp.71~143 (2006), WHO
- Noppadon Tangpukdee, "Gametocyte Clearance in Uncomplicated and Severe Plasmodium falciparum Malaria afterArtesunate-Mefloquine Treatment in Thailand", The Korean Journal of Parasitology, 46(2), pp.65~70 (2008), 대한기생충학회
- Piyaphanee W, "Emergence and clearance of gametocytes in uncomplicated Plasmodium falciparum malaria", Am J Trop Med Hyg, 74, pp.432~435 (2006)
- Na-Bangchang K, "Clinical pharmacology of primaquine. In:Clinical Pharmacology of Antimalarials (1st ed.)", Clinical Pharmacology Unit, Faculty of Tropical Medicine, Mahidol University, 316~ (1993)
- Githeko AK, "The reservoir of Plasmodium falciparum malaria in a holoendmic area of western Kenya", Trans R Soc Trop Med Hyg, 86, pp.355~358 (1992)
- Nassir E, "Impact of genetic complexity on longevity and gametocytogenesis of Plasmodium falciparum during the dry and transmission-free season of eastern Sudan", Int J Parasitol, 35, pp.49~55 (2005)
- Schneider P, "Quantification of Plasmodium falciparum gametocytes in differential stages of development by quantitative nucleic acid sequence-based amplification", Mol Biochem Parasitol, 137, pp.35~41 (2004)
- Schneider P, "(Sub)microscopic Plasmodium falciparum gametocytemia in Kenyan children after treatment with sulfadoxinepyrimethamine monotherapy or in combination with artesunate", Int J Parasitol, 36, pp.403~408 (2006)
- White NJ, "The role of anti-malarial drugs in eliminating malaria", Malaria J, 7(suppl 1), pp.S8~ (2008)
- Talman AM, "Influence of chemotherapy on the Plasmodium gametocyte sex ratio of mice and humans", Am J Trop Med Hyg, 71, pp.739~744 (2004)
- Talman AM, "Gametocytogenesis: the puberty of Plasmodium falciparum", Malar J, 3, pp.24~ (2004)
- Eichner M, "Genetics, sequestration and survival of Plasmodium falciparum gametocytes: parameter estimates from fitting a model to malaria therapy data", Trans R Soc Trop Med Hyg, 95, pp.497~501 (2001)
- Robert V, "Biologie de la transmission homme-moustique du Plasmodium", Bull Soc Pathol Exot, 96, pp.6~20 (2003)
- Sinden RE, "Sexual development of malaria parasite", Adv Parasitol, 22, pp.153~216 (1983)
- Smalley ME, "Plasmodium falciparum gametocytes: their longevity and infectivity", Parasitology, 74, pp.1~8 (1977)
- Field JW, "The microscopic diagnostic of human malaria. In A Morphological Study of the Erythrocytic Parasites", pp.142~ (1956), Government Press
- Pukrittayakamee S, "The effects of different antimalarial drugs on gametocyte carriage in Plasmodium vivax malaria", Am J Trop Med Hyg, 79, pp.378~384 (2008)